Ana Pedrero Gil/LinkedIn
Jul 24, 2026, 04:53
Ana Pedrero Gil: The Future of Blood-Derived Therapies
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Kerstin Wendland et al., published in Transfusion Medicine and Hemotherapy, adding:
“Donated blood is no longer used only as standard transfusion components but is increasingly being developed into new types of therapies.
This review explains recent progress in turning plasma, red blood cells (RBCs), platelets, donor stem cells, and cord blood into more advanced medical products.”
Title: From Donation to Innovation: New Blood-Derived Products
Authors: Kerstin Wendland, Kathleen Selleng, Konstanze Aurich
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 19, 2026, 18:03Manisha Madkaikar: Clinical, Hematological, and Molecular Features of Sickle β-Thalassemia
-
Sep 19, 2026, 17:24Jan Shawqi Goran: Understanding Beta Thalassemia Before Marriage Testing
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment
-
Sep 19, 2026, 10:47Amber Yates: Inside Agios’ Partnership with the Sickle Cell Community